Cargando…
Withdrawal Notice
Withdrawal Notice: Zhu, Y, Pu, Q, Zhang, Q, et al. Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small‐cell lung cancer. Cancer Med. 2022; 00: 1‐22. doi: 10.1002/cam4.5306. The above article, published online on 13th November 2022 in W...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557851/ https://www.ncbi.nlm.nih.gov/pubmed/36372952 http://dx.doi.org/10.1002/cam4.5306 |
_version_ | 1785117160954134528 |
---|---|
collection | PubMed |
description | Withdrawal Notice: Zhu, Y, Pu, Q, Zhang, Q, et al. Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small‐cell lung cancer. Cancer Med. 2022; 00: 1‐22. doi: 10.1002/cam4.5306. The above article, published online on 13th November 2022 in Wiley Online Library (https://onlinelibrary.wiley.com/doi/10.1002/cam4.5306), has been withdrawn by agreement between the journal Editor in Chief, Dr Stephen Tait, the Authors, and John Wiley & Sons, Ltd. The withdrawal has been agreed due to an editorial office error that led to the publication of the article without peer review. The revised article, which has undergone peer review may be read here: https://onlinelibrary.wiley.com/doi/10.1002/cam4.6309. |
format | Online Article Text |
id | pubmed-10557851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105578512023-10-07 Withdrawal Notice Cancer Med Withdrawal Notice Withdrawal Notice: Zhu, Y, Pu, Q, Zhang, Q, et al. Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small‐cell lung cancer. Cancer Med. 2022; 00: 1‐22. doi: 10.1002/cam4.5306. The above article, published online on 13th November 2022 in Wiley Online Library (https://onlinelibrary.wiley.com/doi/10.1002/cam4.5306), has been withdrawn by agreement between the journal Editor in Chief, Dr Stephen Tait, the Authors, and John Wiley & Sons, Ltd. The withdrawal has been agreed due to an editorial office error that led to the publication of the article without peer review. The revised article, which has undergone peer review may be read here: https://onlinelibrary.wiley.com/doi/10.1002/cam4.6309. John Wiley and Sons Inc. 2022-11-13 /pmc/articles/PMC10557851/ /pubmed/36372952 http://dx.doi.org/10.1002/cam4.5306 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Withdrawal Notice Withdrawal Notice |
title | Withdrawal Notice |
title_full | Withdrawal Notice |
title_fullStr | Withdrawal Notice |
title_full_unstemmed | Withdrawal Notice |
title_short | Withdrawal Notice |
title_sort | withdrawal notice |
topic | Withdrawal Notice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557851/ https://www.ncbi.nlm.nih.gov/pubmed/36372952 http://dx.doi.org/10.1002/cam4.5306 |